The Short Version of the Borderline Symptom List (BSL-23): Development and Initial Data on Psychometric Properties
The Short Version of the Borderline Symptom List (BSL-23): Development and Initial Data on Psychometric Properties
复制标题
DOI：
10.1159/000173701
复制
发表时间：
2009-01-01
期刊：
影响因子：
3.6
通讯作者：
Wolf, Martina
中科院分区：
文献类型：
--
作者：
Bohus, Martin;Kleindienst, Nikolaus;Wolf, Martina
背景资料：完整版的边缘症状列表（BSL;为澄清起见，现标记为BSL-95）是一种自我评定工具，用于特定评估边缘-典型的精神病学。BSL-95项目是基于DSM-IV标准，修订版的边缘性人格障碍诊断访谈，以及临床专家和边缘患者的意见。BSL-95包括95个项目。为了减少患者负担和评估时间，开发了包含23个项目的简短版本（BSL-23）。研究方法：BSL-23的开发是基于379名边缘患者的样本，考虑到BSL-95中对变化敏感度最高的项目，以及区分边缘患者与其他患者群体的能力最高的项目。在第二步中，BSL-23的心理测量学特性进行了调查，并与BSL-95的心理测量学特性在5个不同的样本，包括共659个边缘患者进行了比较。结果：在所有样本中，BSL-23与BSL-95总分之间存在高度相关性（范围：0.958-0.963）。两个版本的内部一致性都很高（BSL-23/Cronbach α：0.935-0.969; BSL-95/Cronbach α：0.977-0.978）。BSL-23和BSL-95都能明显区分边缘型人格障碍患者和轴I诊断患者（BSL-23和BSL-95的平均效应量分别为1.13和0.96）。此外，辩证行为治疗3个月前后的比较显示，BSL-23（d = 0.47）的效应量在数值上大于BSL-95（d = 0.38）。结论：结果表明，BSL-23是一个有效的和方便的自评工具，显示出良好的心理测量性能相媲美的BSL-95。BSL-23也表现出对治疗效果的敏感性。版权所有（C）2008 S. Karger AG，巴塞尔
Background: The full version of the Borderline Symptom List (BSL; for clarification now labeled BSL-95) is a self-rating instrument for specific assessment of borderline-typical symptomatology. The BSL-95 items are based on criteria of the DSM-IV, the revised version of the Diagnostic Interview for Borderline Personality Disorder, and the opinions of both clinical experts and borderline patients. The BSL-95 includes 95 items. In order to reduce patient burden and assessment time, a short version with 23 items (BSL-23) was developed. Methods: The development of the BSL-23 was based on a sample of 379 borderline patients, considering the items from the BSL-95 that had the highest levels of sensitivity to change and the highest ability to discriminate borderline patients from other patient groups. In a second step, the psychometric properties of the BSL-23 were investigated and compared with the psychometric properties of the BSL-95 in 5 different samples, including a total of 659 borderline patients. Results: In all of the samples, a high correlation of the sum score was found between the BSL-23 and the BSL-95 (range: 0.958-0.963). The internal consistency was high for both versions (BSL-23/Cronbach's alpha: 0.935-0.969; BSL-95/Cronbach's alpha: 0.977-0.978). Both BSL-23 and BSL-95 clearly discriminated borderline personality disorder patients from patients with an axis I diagnosis (mean effect sizes were 1.13 and 0.96 for the BSL-23 and BSL-95, respectively). In addition, comparisons before and after 3 months of dialectical behavior therapy revealed a numerically larger effect size for the BSL-23 (d = 0.47) compared to the BSL-95 (d = 0.38). Conclusion: The results indicate that the BSL-23 is an efficient and convenient self-rating instrument that displays good psychometric properties comparable to those of the BSL-95. The BSL-23 also demonstrated sensitivity to the effects of therapy. Copyright (C) 2008 S. Karger AG, Basel